Showing results (51-60 of 84) with videos related to
Sort By:
Pageof 9
Gynecologic Oncology|July 1, 1993
Evidence supporting the superiority of intraperitoneal cisplatin compared to intraperitoneal carboplatin for salvage therapy of small-volume residual ovarian cancerM Markman, B Reichman, T Hakes, et al.Gynecologic Oncology|May 1, 1993
Salvage intraperitoneal mitoxantrone therapy of ovarian cancer: influence of increasing the volume of treatmentM Markman, T Hakes, B Reichman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide coursesD Fennelly, J Schneider, D Spriggs, et al.Gynecologic Oncology|December 11, 1992
Phase 2 trial of intraperitoneal carboplatin and etoposide as salvage treatment of advanced epithelial ovarian cancerM Markman, B Reichman, T Hakes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 1991
Intraperitoneal cisplatin and cytarabine in the treatment of refractory or recurrent ovarian carcinomaM Markman, T Hakes, B Reichman, et al.Cancer|February 15, 1993
National survey of ovarian carcinoma. I. A patient care evaluation study of the American College of SurgeonsH E Averette, W Hoskins, H N Nguyen, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 1, 1994
Symptom prevalence, characteristics and distress in a cancer populationR K Portenoy, H T Thaler, A B Kornblith, et al.The Journal of Infectious Diseases|June 2, 1998
A preliminary evaluation of nelfinavir mesylate, an inhibitor of human immunodeficiency virus (HIV)-1 protease, to treat HIV infectionM Markowitz, M Conant, A Hurley, et al.Cell Genomics|October 17, 2025
Predictive prioritization of enhancers associated with pancreatic disease riskLi Wang, Songjoon Baek, Gauri Prasad, et al.Biorxiv : the Preprint Server for Biology|September 24, 2024
Predictive Prioritization of Enhancers Associated with Pancreas Disease RiskLi Wang, Songjoon Baek, Gauri Prasad, et al.Pageof 9